Cargando…

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review

Detalles Bibliográficos
Autores principales: Parker, Edward P K, Desai, Shalini, Marti, Melanie, Nohynek, Hanna, Kaslow, David C, Kochhar, Sonali, O'Brien, Katherine L, Hombach, Joachim, Wilder-Smith, Annelies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846615/
https://www.ncbi.nlm.nih.gov/pubmed/35180408
http://dx.doi.org/10.1016/S2214-109X(21)00593-3
_version_ 1784651880643690496
author Parker, Edward P K
Desai, Shalini
Marti, Melanie
Nohynek, Hanna
Kaslow, David C
Kochhar, Sonali
O'Brien, Katherine L
Hombach, Joachim
Wilder-Smith, Annelies
author_facet Parker, Edward P K
Desai, Shalini
Marti, Melanie
Nohynek, Hanna
Kaslow, David C
Kochhar, Sonali
O'Brien, Katherine L
Hombach, Joachim
Wilder-Smith, Annelies
author_sort Parker, Edward P K
collection PubMed
description
format Online
Article
Text
id pubmed-8846615
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd
record_format MEDLINE/PubMed
spelling pubmed-88466152022-02-16 Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review Parker, Edward P K Desai, Shalini Marti, Melanie Nohynek, Hanna Kaslow, David C Kochhar, Sonali O'Brien, Katherine L Hombach, Joachim Wilder-Smith, Annelies Lancet Glob Health Correspondence Elsevier Ltd 2022-02-15 /pmc/articles/PMC8846615/ /pubmed/35180408 http://dx.doi.org/10.1016/S2214-109X(21)00593-3 Text en © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/3.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Correspondence
Parker, Edward P K
Desai, Shalini
Marti, Melanie
Nohynek, Hanna
Kaslow, David C
Kochhar, Sonali
O'Brien, Katherine L
Hombach, Joachim
Wilder-Smith, Annelies
Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
title Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
title_full Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
title_fullStr Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
title_full_unstemmed Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
title_short Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
title_sort response to additional covid-19 vaccine doses in people who are immunocompromised: a rapid review
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846615/
https://www.ncbi.nlm.nih.gov/pubmed/35180408
http://dx.doi.org/10.1016/S2214-109X(21)00593-3
work_keys_str_mv AT parkeredwardpk responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview
AT desaishalini responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview
AT martimelanie responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview
AT nohynekhanna responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview
AT kaslowdavidc responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview
AT kochharsonali responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview
AT obrienkatherinel responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview
AT hombachjoachim responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview
AT wildersmithannelies responsetoadditionalcovid19vaccinedosesinpeoplewhoareimmunocompromisedarapidreview